Shandong Boan Biotechnology Co., Ltd. (HKG:6955)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.26
+0.18 (2.54%)
At close: Mar 10, 2026
-17.03%
Market Cap 4.41B
Revenue (ttm) 829.27M
Net Income (ttm) 35.10M
Shares Out 622.33M
EPS (ttm) 0.06
PE Ratio 114.67
Forward PE 24.04
Dividend n/a
Ex-Dividend Date n/a
Volume 3,977,200
Average Volume 2,999,370
Open 7.13
Previous Close 7.08
Day's Range 7.13 - 7.35
52-Week Range 6.78 - 25.00
Beta -0.46
RSI 38.39
Earnings Date Mar 26, 2026

About HKG:6955

Shandong Boan Biotechnology Co., Ltd., a biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China. The company offers Boyounuo (BA1101), an anti-VEGF humanized monoclonal antibody injection for mCRC, advanced metastatic or recurrent non-small cell lung cancer, recurrent glioblastoma, epithelial ovarian, fallopian tube, primary peritoneal cancer, cervical cancer, and hepatocellular carcinoma indications; Boyoubei (BA6101), a human immunoglobulin G2 monoclonal antibody of the RANK ligand for the treatment of post... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 714
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6955
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.